Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

LOL! You are right - there are many unknowns which

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 310)
Posted On: 12/28/2019 10:18:55 PM
Posted By: Paul Jackson
Re: Buildit #10387
LOL! You are right - there are many unknowns which can possibly jeopardize the $2M net tangible assets needed for the uplist. And you are totally right that we should look at the uplist as a result to positive business practices/progress, not the catalyst for the stock.

A few things I'd like to mention that helps the $2M tangible assets -

1. Last Q net loss was $9.2MM, if you look at Note 10 of the 10Q, the $9.2M includes $3,033,820 increase in derivative liability during the quarter because of Veneto...so, with Veneto violation, GNBT is no longer liable for the derivative liability, so the $9.2M loss should have been $6.2M loss instead.

2. Because of the Veneto violation, $6M liability will be wiped out...the way to wipe out an liability on GNBT's books is to increase other income...so, next 10Q should reflect extra $6M in other income under "change in fair value of derivative liability."

3. The $2.2MM bridge loan - it will show up as cash of $2.2M and Note payable of $2.2M, so the effect on net tangible assets is zero. Also, I don't think it is part of the $40M. Please see notes from 10Q, copied and pasted here -

From 10Q -

On November 25, 2019, the Company entered an Equity Purchase Agreement with an investor to purchase up to $40,00,000 of the Company’s stock at 92% of the market price for the period of five (5) consecutive trading days immediately subject to a put notice on such date on which the Purchase Price is calculated in accordance with the terms and conditions of this Agreement and in which 1,228,501 shares of common stock (“Commitment Shares”) upon signing will be issued to an investor.

On December 5, 2019, we closed under a securities purchase agreement with an investor pursuant to which we sold a convertible note bearing interest at 12% per year in the principal amount of $2,200,000. The purchase price of the note was $2,000,000 and the remaining $200,000 of principal amount represents original issue discount and issued 100,000 shares of common stock for the commitment.

4. Joe mentioned during the 11/29 cc, they are hoping to raise $30M more, but some investors will only invest after the S1 is filed

Copied and pasted from 11/29 cc -

Joe said -
We have definitive documents for $40 million in equity. That will give us enough capital over the next two or three years to build everything we need. We're not going to stop there--the goal is 70, we believe we can get there. I would like to see the share price go up a little bit more. But I will say we will file the S-1 immediately--hopefully, by the end of next week. And then we can add to it if we're able to get one of the other interested funds that requires the S-1 to be filed to invest.

SO, in summary, you are right that there are many unknowns, but maybe $2M net tangible assets is still possible...



Buildit wrote -

Purely for fun, and not trying to be an ass... I’ll continue the speculation

Just a few other items I can think of that we know:
Last Q Op Loss was $4.55MM, Net Loss was $9.2MM, and the $2.5MM bridge loan will come out of the S-1 $ but not show on the last Q liabilities. So that could wipe out the $7.8MM or more.

A few things we don’t know:
Depending how much $ Joe is spending now on attorneys/consultants, etc this Q, that could be a decent number.
How will ALTuCell affect assets and liabilities?
Did any obligations roll up in cost due to the low stock price that is being used to find many things right now?

Again, I think we should look at the uplist as a result to positive business practices/progress, not the catalyst for the stock. That was a nice thought while it lasted, but execution is the key now...

Read More: https://investorshangout.com/post/newpost/622...z69SbLIMvd


(3)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us